SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-074712
Filing Date
2012-11-06
Accepted
2012-11-06 16:02:13
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-19742_110q.htm 10-Q 1012092
2 EX-10.1 a12-19742_1ex10d1.htm EX-10.1 46474
3 EX-31.1 a12-19742_1ex31d1.htm EX-31.1 9665
4 EX-31.2 a12-19742_1ex31d2.htm EX-31.2 9708
5 EX-32.1 a12-19742_1ex32d1.htm EX-32.1 7338
12 GRAPHIC g197421kei001.gif GRAPHIC 5677
  Complete submission text file 0001104659-12-074712.txt   9640082

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT isis-20120930.xml EX-101.INS 1170821
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isis-20120930.xsd EX-101.SCH 121446
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isis-20120930_cal.xml EX-101.CAL 42744
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT isis-20120930_lab.xml EX-101.LAB 1920480
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isis-20120930_pre.xml EX-101.PRE 853524
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isis-20120930_def.xml EX-101.DEF 612239
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 121183249
SIC: 2834 Pharmaceutical Preparations